Results

Total Results: 107 records

Showing results for "episodes".

1. CHIPRA 213: Section 5, Table 4 (pdf file)
   www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
   January 01, 2012 - Lancet of renal and spleen function, subjects receiving 2011; 377(9778): 1663‐ the drug had few episodes … hydroxyurea therapy in children and adolescents are HbSS (SCA) or SCD‐S β0‐ thalassemia and frequent pain episodes … administration of hydroxyurea increases HbF levels, decreases leukocyte counts, and decreases the frequency of episodes … stated that “Strong evidence supports the efficacy of hydroxyurea in adults to decrease severe painful episodes

2. Section 1, Table 1. Definitions of Three Levels of Medical Complexity (pdf file)
   www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-141-section-1-table-1.pdf
   June 28, 2017 - commonly lifelong but can be episodic with defect, asthma, depression, periods of good health in between episodes

3. Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
   www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-fullreport.pdf
   April 01, 2018 - sickle shape of abnormal blood cells) is responsible for most complications of SCD, including pain episodes … Pain episodes, which are caused when blood flow is impeded to various parts of the body, tend to be … Without prompt assessment and treatment, painful episodes that are of mild to moderate severity may … On average, pain crises persist for 4 to 5 days, though protracted episodes may last for 2 to 3 weeks … Pain associated with vaso‐occlusive episodes usually involves two to three sites and may be migratory

4. Catheter Ablation for Atrial Fibrillation: Topic Refinement - Project ID: CRDT0913 (pdf file)
   www.cahps.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/afib_topicref.pdf
   January 01, 2020 - that last > 7 days) o Paroxysmal AF (recurrent episodes that self-terminate in < 7 days) • Subgroups … Paroxysmal AF: Recurrent AF (≥2 episodes) that terminates spontaneously within 7 days. … should also be classified as paroxysmal AF episodes. … Episodes of AF in which a decision is made to electrically or pharmacologically cardiovert the patient … after ≥ 48 hours of AF, but prior to 7 days, should also be classified as persistent AF episodes.

5. Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
   www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-scd-pain-specifications.pdf
   April 14, 2018 - Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease 1 Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment for Children with Sickle Cell Disease Description The percentage of children identified as having S…

6. Section 5, Table 3 (pdf file)
   www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-5-table-3.pdf
   August 01, 2014 - The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of

7. Key Driver Diagram | Agency for Healthcare Research and Quality
   www.cahps.ahrq.gov/pqmp/implementation-qi/toolkit/asthma/key-drivers.html
   July 01, 2021 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

8. Delivery System Research Initiative | Agency for Healthcare Research and Quality
   www.cahps.ahrq.gov/practiceimprovement/delivery-initiative/index.html
   December 01, 2020 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

9. Advancing the Impact of Consumer Experience of Care Measurement: What’s Next? | Agency for Healthcare Research and Quality
   www.cahps.ahrq.gov/news/blog/ahrqviews/consumer-experience-measurement.html
   September 01, 2023 - It is provided in multiple episodes, often in multiple settings and by multiple clinicians.

10. Section II: Detailed Measure Specifications (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0134-technicalspecs.pdf
    January 01, 2011 - Section II: Detailed Measure Specifications Section II: Detailed Measure Specifications Provide sufficient detail to describe how a measure would be calculated from the recommended data sources, uploading a separate document (+ Upload attachment) or a link …

11. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
    www.cahps.ahrq.gov/policymakers/chipra/overview/background/next-steps2.html
    December 01, 2009 - Many episodes resolve spontaneously within 3 months, but about 30 percent to 40 percent of children have … recurrent OME, and 5 percent to 10 percent of episodes last 1 year or longer.

12. TeamSTEPPS Specialty Scenarios: Neonatal ICU (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/teamstepps/instructor/scenarios/neonatalicu.pdf
    March 19, 2014 - resident and tells him that she is concerned about the baby’s color and that the baby is having more ABD episodes

13. Ohio Veterans’ Facility Relied on AHRQ Resource to Develop Diabetes Initiative | Agency for Healthcare Research and Quality
    www.cahps.ahrq.gov/news/newsroom/case-studies/202301.html
    March 01, 2023 - And they feel much better when they don’t experience hypoglycemic episodes.”

14. MEASURE SUMMARY (CHIPRA Core Set Candidate Measures) - Control #: AC-2 (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/measures-AC-2.pdf
    December 16, 2010 - MEASURE SUMMARY (CHIPRA Core Set Candidate Measures) - Control #: AC-2 Completed by: Page 1 12/16/2010 MEASURE SUMMARY CHIPRA Core Set Candidate Measures A. Control #: AC-2 B. Measure Name: Pharyngitis-appropriate testing C. Measure Definition a. Numerator: A strep test was administered in the 7-day…

15. PQMP National Asthma Quality Metric Key Driver Diagram (Vermont) (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/keydriver-vtcollaborative.pdf
    January 24, 2018 - PQMP National Asthma Quality Metric Key Driver Diagram (Vermont) PQMP National Asthma Quality Metric Key Driver Diagram (Vermont) – (I)Prevention/(II)Acute Episode/ (III)ED Care Global Aim: We aim to test and implement national performance measures that accurately assesses components of quality care for c…

16. PQMP National Asthma Quality Metric Key Driver Diagram (UCSF) (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/keydriver-sfcollaborative.pdf
    January 24, 2018 - PQMP National Asthma Quality Metric Key Driver Diagram (UCSF) PQMP National Asthma Quality Metric Key Driver Diagram (UCSF)  – (I)Prevention/(II)Acute Episode/ (III)ED Care Global Aim:  We aim to test and  implement national  performance  measures that  accurately assesses  components of  quality care for  childre…

17. Adolescent Depression Remission/Response (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
    December 01, 2019 - experiences just one episode of depression, he or she is at a 50 percent higher risk of experiencing further episodes … If such symptoms and/or episodes persist in a manner that significantly impacts day-to-day life, a single

18. Anticipatory Guidance Regarding Hydroxyurea Treatment for Children With Sickle Cell Anemia (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-fullreport.pdf
    January 01, 2019 - for pediatric patients with SCA who have recurrent vaso‐occlusive events, including frequent pain episodes … sickle shape of abnormal blood cells) is responsible for most complications of SCD, including pain episodes … Disease Burden in Daily Life The effect of SCD on children and families is significant; severe pain episodes … This aggregation blocks blood flow to the organs and limbs, causing painful episodes and permanent damage … findings that this medication improves hematologic variables and decreases hospitalization rates, pain episodes

19. Depression Remission or Response for Adolescents and Adults: Report (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
    December 01, 2019 - experiences just one episode of depression, he or she is at a 50 percent higher risk of experiencing further episodes … If such symptoms and/or episodes persist in a manner that significantly impacts day-to-day life, a single

20. Table 5. Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
    April 01, 2014 - Many uncomplicated episodes can be managed at home with oral fluids; oral analgesics (ibuprofen, acetaminophen